메뉴 건너뛰기




Volumn 8, Issue 19, 2002, Pages 1749-1764

Monoclonal antibody-based therapy strategies: Providing options for the cancer patient

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBODY CONJUGATE; ANTIIDIOTYPIC ANTIBODY; BISPECIFIC ANTIBODY; CALICHEAMICIN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CHLORAMBUCIL; CISPLATIN; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; EDRECOLOMAB; EPRATUZUMAB; FLUOROURACIL; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IBRITUMOMAB TIUXETAN; IMMUNOGLOBULIN G2A; MELPHALAN; METHOTREXATE; MITOMYCIN; MONOCLONAL ANTIBODY; PACLITAXEL; RADIOISOTOPE; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB; TRIAZIQUONE; TUMOR ANTIGEN; UNINDEXED DRUG; ANTINEOPLASTIC AGENT; IMMUNOTOXIN; PRODRUG;

EID: 0035988624     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612023393963     Document Type: Review
Times cited : (51)

References (164)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.